A Novel Clinically Relevant Strategy to Abrogate Autoimmunity and Regulate Alloimmunity in NOD Mice

OBJECTIVE: To investigate a new clinically relevant immunoregulatory strategy based on treatment with murine Thymoglobulin mATG Genzyme and CTLA4-Ig in NOD mice to prevent allo- and autoimmune activation using a stringent model of islet transplantation and diabetes reversal. RESEARCH DESIGN AND METH...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Vergani, Andrea, D'Addio, Francesca, Jurewicz, Mollie, Petrelli, Alessandra, Watanabe, Toshihiko, Liu, Kaifeng, Law, Kenneth, Schuetz, Christian, Carvello, Michele, Orsenigo, Elena, Deng, Shaoping, Rodig, Scott J., Ansari, Javeed M., Staudacher, Carlo, Abdi, Reza, Williams, John, Markmann, James, Atkinson, Mark, Sayegh, Mohamed H., Fiorina, Paolo
Formato: Artigo
Idioma:Inglês
Publicado: American Diabetes Association 2010
Assuntos:
Immunology and Transplantation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2927948/
https://ncbi.nlm.nih.gov/pubmed/20805386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db09-1264
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares